Safety and Efficacy of ECMT-100 for the Treatment of Anorectal Fistulas
ECMT-100 is a colloidal hydrogel derived from extracellular matrix (ECM), formulated to adhere to sub-epithelial soft tissue and allow for filling of anorectal fistulas to reinforce and promote fistula tract closure. ECMT-100 is a medical device and should be administered via catheter within the fistula tract following curettage of the tract, with draining setons used preoperatively. ECMT-100 is a mucoadhesive hydrogel composed of ECM formulated to adhere to the gastrointestinal mucosa, fill the transsphincteric fistula tract, and promote tract closure by allowing for timely host tissue integration without fecal incontinence.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
10
Colloidal hydrogel
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
RECRUITINGUniversity of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
RECRUITINGAdverse Events
Number of Adverse Events
Time frame: 12 months from treatment
Percentage of Subjects in whom external openings of the fistula have closed
Physical exam to confirm closure and absence of discharge
Time frame: 12 months from treatment
Changes in Fecal Incontinence
Wexner Score - Cleveland Clinic Fecal Incontinence Score; changes from baseline
Time frame: 12 months from treatment
Changes in Quality of Life
Medical Outcomes Study Questionnaire Short Form 36; changes from baseline
Time frame: 12 months from treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.